Know Cancer

or
forgot password


Phase 3
70 Years
N/A
Not Enrolling
Both
Primary Brain Tumor, Anaplastic Astrocytoma, Glioblastoma Multiforme

Thank you

Trial Information


Inclusion Criteria:



- Glioblastoma and anaplastic astrocytoma, supratentorial, histologically confirmed

- Brain CT scan or MRI within 28 days before surgery

- Age: 70 years or older

- Karnofsky performance status, 70 or more.

- Life expectancy over 12 weeks

- Informed consent

Exclusion Criteria:

- Brain radiotherapy

- Chemotherapy

- Severe systemic disease

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Survival

Principal Investigator

jean-yves Delattre, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Assistance Publique - Hôpitaux de Paris

Authority:

France: Ministry of Health

Study ID:

PHRC, P000502 AOM 98071

NCT ID:

NCT00430911

Start Date:

February 2001

Completion Date:

Related Keywords:

  • Primary Brain Tumor
  • Anaplastic Astrocytoma
  • Glioblastoma Multiforme
  • malignant gliomas
  • Astrocytoma
  • Brain Neoplasms
  • Glioblastoma

Name

Location